Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR).

Transplantation and cellular therapy·2026
Same author

Synthesis of Phenyl 2-Acetamidoselenogalactoside Mimetics and Interaction with Amyloid β<sub>1-42</sub>.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

TREM-1-Linked Inflammatory Cargo in SARS-CoV-2-Stimulated Macrophage Extracellular Vesicles Drives Cellular Senescence and Impairs Antibacterial Defense.

Viruses·2025
Same author

T-cell Recovery After Autologous Hematopoietic Stem Cell Transplantation in Autoimmune Diseases.

Advances in experimental medicine and biology·2025
Same author

Carbon Nanomaterials with SOD-like Activity: The Effect of the Ionic Strength.

Molecules (Basel, Switzerland)·2024
Same author

Effect of lipid oxidation on the channel properties of Cx26 hemichannels: A molecular dynamics study.

Archives of biochemistry and biophysics·2023
Same journal

China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report.

Kidney international supplements·2025
Same journal

Variations in kidney care management and access: regional assessments of the 2023 International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024
Same journal

Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024
Same journal

Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024
Same journal

Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024
Same journal

Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

4.4K

Stem cell therapy for diabetes mellitus.

Júlio C Voltarelli1, Carlos E B Couri1, Maria C Oliveira1

  • 1Department of Clinical Medicine, Ribeirão Preto School of Medicine, University of São Paulo , São Paulo, Brazil.

Kidney International Supplements
|July 15, 2014
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cell transplantation (HSCT) shows promise for treating severe autoimmune diseases (AIDs), including type 1 diabetes mellitus (T1DM). Further research explores novel stem cell sources and regenerative compounds for improved therapeutic outcomes.

Keywords:
diabetes mellitushematopoietic stem cellstem cell therapy

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells
08:34

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

Published on: March 3, 2016

7.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

4.4K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells
08:34

A Quick and Efficient Method for the Purification of Endoderm Cells Generated from Human Embryonic Stem Cells

Published on: March 3, 2016

7.9K

Area of Science:

  • Immunology
  • Endocrinology
  • Hematology

Background:

  • Autoimmune diseases (AIDs) pose significant challenges, necessitating innovative therapeutic strategies.
  • Hematopoietic stem cell transplantation (HSCT) has emerged as a potential treatment for severe and refractory AIDs since 1996.
  • Type 1 diabetes mellitus (T1DM) is a key focus for HSCT research in autoimmune conditions.

Approach:

  • This review synthesizes the evolution of HSCT for AIDs, from early applications to current randomized clinical trials.
  • It provides an updated analysis of clinical and laboratory outcomes for 23 T1DM patients treated with autologous HSCT.
  • The review discusses potential mechanisms of HSCT action in AIDs, supported by preliminary patient data.

Key Points:

  • Autologous HSCT outcomes in 23 newly diagnosed T1DM patients are detailed.
  • Mechanisms underlying HSCT efficacy in AIDs are explored, including novel laboratory findings.
  • The study highlights the potential of HSCT in managing refractory autoimmune conditions.

Conclusions:

  • HSCT represents a viable therapeutic option for severe autoimmune diseases, including T1DM.
  • Future directions involve exploring alternative stem cell sources beyond adult bone marrow.
  • Combining cell therapy with regenerative compounds offers promising avenues for T1DM and type 2 diabetes mellitus (T2DM).